- Home
- PCG vs ALC Comparison
PCG vs ALC Comparison
Compare PCG & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCG
- ALC
- Stock Information
- Founded
- PCG 1905
- ALC 1945
- Country
- PCG United States
- ALC Switzerland
- Employees
- PCG N/A
- ALC N/A
- Industry
- PCG Power Generation
- ALC Ophthalmic Goods
- Sector
- PCG Utilities
- ALC Health Care
- Exchange
- PCG Nasdaq
- ALC Nasdaq
- Market Cap
- PCG 37.7B
- ALC 41.0B
- IPO Year
- PCG N/A
- ALC N/A
- Fundamental
- Price
- PCG $17.00
- ALC $84.37
- Analyst Decision
- PCG Strong Buy
- ALC Strong Buy
- Analyst Count
- PCG 13
- ALC 14
- Target Price
- PCG $22.62
- ALC $102.53
- AVG Volume (30 Days)
- PCG 25.3M
- ALC 801.5K
- Earning Date
- PCG 02-13-2025
- ALC 02-25-2025
- Dividend Yield
- PCG 0.32%
- ALC 0.31%
- EPS Growth
- PCG 48.83
- ALC 156.61
- EPS
- PCG 1.28
- ALC 2.34
- Revenue
- PCG $24,829,000,000.00
- ALC $9,761,000,000.00
- Revenue This Year
- PCG $2.26
- ALC $5.43
- Revenue Next Year
- PCG $4.11
- ALC $6.42
- P/E Ratio
- PCG $13.29
- ALC $35.98
- Revenue Growth
- PCG 9.10
- ALC 5.25
- 52 Week Low
- PCG $15.94
- ALC $74.30
- 52 Week High
- PCG $21.72
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- PCG 29.67
- ALC 46.68
- Support Level
- PCG $15.94
- ALC $82.31
- Resistance Level
- PCG $17.48
- ALC $83.68
- Average True Range (ATR)
- PCG 0.60
- ALC 1.04
- MACD
- PCG -0.29
- ALC 0.14
- Stochastic Oscillator
- PCG 23.61
- ALC 59.71
About PCG Pacific Gas & Electric Co.
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision between January 2019 and June 2020. In 2004, PG&E sold its unregulated assets as part of an earlier postbankruptcy reorganization.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.